Clearwater France has advised the consortium formed by GIMV and Mérieux Développement in the acquisition of Stiplastics.
Stiplastics Healthcaring has over 30 years’ experience in medical plastics. It works with customers throughout the entire process, from formulating the exact needs until the product is launched. It is a recognised specialist in the area of treatment observance, and its range of “intelligent” pill dispensers encourage treatment observance, and make administering and taking medicines easier and safer. It has also built solid expertise in solutions for respiratory diseases. Stiplastics Healthcaring works in partnership with pharmaceutical industry leaders and has recently developed an inhalation device.
This transaction will allow Stiplastics to continue its development in new territories and products, particularly in the domain of liquid based medicine and pharmaceutical containers by associating with other companies. Under the encouragement of its new stakeholders, the group wishes to engage in several new acquisitions in Europe and the United States.
